Video

Anna G. Mackin, MD

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Related Content
Q&A: Kapil Mishra on radiation retinopathy in uveal melanoma
May 21st 2025

Q&A: Kapil Mishra on radiation retinopathy in uveal melanoma

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Viridian Therapeutics announces positive long-term durability data for veligrotug for the treatment of active thyroid eye disease
May 20th 2025

Viridian Therapeutics announces positive long-term durability data for veligrotug for the treatment of active thyroid eye disease

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Astigmatism in Hong Kong children increased substantially following COVID-19 era restrictions
May 20th 2025

Astigmatism in Hong Kong children increased substantially following COVID-19 era restrictions

Ashvattha reports positive phase 2 data for migaldendranib in retinal diseases
May 19th 2025

Ashvattha reports positive phase 2 data for migaldendranib in retinal diseases

© 2025 MJH Life Sciences

All rights reserved.